Composition for resisting ischemia reperfusion injury and preparation method and application thereof
A reperfusion injury and composition technology, applied in the field of anti-ischemia-reperfusion injury composition and its preparation and use, can solve the problems such as preparation method and use of anti-ischemia-reperfusion injury products that have not yet been found
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0569] Example 1. Expression of α7nAChR in mouse liver tissue
[0570] The expression of α7nAChR in the liver tissue of male C57BL / 6 mice was detected by western-blotting method, the mice were sacrificed by dislocation of the cervical spine, the liver tissue was homogenized, the total protein was extracted, and the expression of α7nAChR in the liver tissue was detected, and normal mouse liver tissue was found have α7nAChR expression (see figure 1 ).
Embodiment 2
[0571] Example 2. Changes in liver blood flow during mouse liver ischemia-reperfusion
[0572]C57BL / 6 mice were selected, and the blood flow in the left middle lobe of the liver (hepatic blood flow HBF) was monitored in real time by Doppler flowmeter during partial ischemia-reperfusion surgery. to 32%±0.049, the blood flow stabilized at 17%±0.032 of normal blood flow after 10 minutes of ischemia, the blood flow recovered to 66%±0.112 immediately after the arterial clamp was removed, and the blood flow completely recovered to normal level after 10 minutes (see figure 2 ).
Embodiment 3
[0573] Example 3. Effects of Different Doses of Atr.+Neo. Combined Therapy on Ischemia-Reperfusion Injury
[0574] Taking partial ischemia-reperfusion of the mouse liver as a model, 35 male C57BL / 6 mice (22±2.0g) were randomly divided into five groups, and one group was sutured immediately after laparotomy. The other four groups were injected intraperitoneally with normal saline solution (10ml / kg), PNU-282987 (40μg / kg), Atr.(0.2mg / kg)+Neo.(0.4mg / kg), Atr.(0.1mg / kg) +Neo.(0.2mg / kg), liver ischemia treatment was performed 30min after drug injection, reperfusion was started at 60min after ischemia, and liver tissue was collected at 6h after reperfusion, and the livers of animals in each group were detected by enzyme-linked immunosorbent assay (ELISA) technology Caspase-3, 8, 9 activity (see image 3 ).
[0575] The results showed that: compared with the normal control group, the activity of Caspase-3, 8, and 9 in the model group was significantly increased ( ** P*** P<0.001, n...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com